The U.S. Homeland Security Dept. yesterday warned of two more cybersecurity vulnerabilities with the Alaris infusion pump made by Becton, Dickinson (NYSE:BDX).
The DHS Industrial Control Systems Cyber Emergency Response Team, acting on weaknesses unearthed by researchers at CyberMDX, said the vulnerabilities could allow a malicious attacker to completely disable BD’s Alaris Gateway Workstation and install malware or report false information. The attacker could also exploit the flaw to communicate directly with the pumps to change drug dosages and infusion rates, ICS-CERT said.
Get the full story on our sister site, Drug Delivery Business.